loader
Please Wait
Applying Filters...
Promoted Content
Promoted Content

List of Etizolam Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Client Email Product
Left Arrow
Right Arrow
Filters Filter
×
FILTER DATA :

filter

Etizolam

etizolam

filter

CHINA

INDIA

UNITED STATES

PreviewPreview

Virtual Booth> 30 Yrs of Experience in Quality APIs & Intermediates Manufacturing

RL Fine Chem Pvt. Ltd. is among the fastest growing API companies, with a leadership position in several APIs in the therapeutic areas including Antihistaminic, Antidepressants and Muscle Relaxants. We are one of India's leading psychotropic substances manufacturers, we supply over 60 APIs to customers in more than 62 countries from our FDA/EU appr...
RL Fine Chem Pvt. Ltd. is among the fastest growing API companies, with a leadership position in several APIs in the therapeutic areas including Antihistaminic, Antidepressants and Muscle Relaxants. We are one of India's leading psychotropic substances manufacturers, we supply over 60 APIs to customers in more than 62 countries from our FDA/EU approved locations. We are a technology driven company with focus on in-house manufacture of key intermediate for our APIs.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

To improve the quality of life for patients by providing them with products which are Safe, Effective, High Quality and Affordable price. Bal Pharma is a fully integrated and leading Indian Pharmaceutical Company specializing in Prescription drugs, Generic, OTC products, Intravenous Infusion and Bulk Actives with almost 19 years of experience beh...
To improve the quality of life for patients by providing them with products which are Safe, Effective, High Quality and Affordable price. Bal Pharma is a fully integrated and leading Indian Pharmaceutical Company specializing in Prescription drugs, Generic, OTC products, Intravenous Infusion and Bulk Actives with almost 19 years of experience behind it. Bal Pharma’s API’s and Formulations are produced at world class manufacturing facilities. API’s are exported to Europe, Latin America, Africa, Middle East and Asian markets. Formulation products are exported to Semi-Regulated and Non Regulated markets and s strong contender for Tender business in various markets especially Asian markets. With the new facility being set up in Uttaranchal, as per ICH and PIC guidelines to meet the requirements of USFDA and various European MOH, the company plans to enter in to Regulated Markets by 2010 and already in talks for Contract Manufacturing for clients in Regulated Markets. Successful Operations in Domestic and International markets, backed by its strength in Research and strong Infrastructure frame work have accelerated Bal Pharma’s growth from oblivience to reach a turn over of USD 25 million today. Buoyed by the past, the group has put in motion a fast track growth target and has set its sigh on sales in excess of USD 150 million by 2015.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Beijing Cooperate Pharmaceutical Co.,Ltd is a high-tech company specializing in pharmaceutical and advanced material, involving API,pharmaceutical intermediates and petrochemical additives . we are the direct producer of some kinds of new pharmaceutical intermediates products what can be use for the treatment of disease of heart head blood-vessel, ...
Beijing Cooperate Pharmaceutical Co.,Ltd is a high-tech company specializing in pharmaceutical and advanced material, involving API,pharmaceutical intermediates and petrochemical additives . we are the direct producer of some kinds of new pharmaceutical intermediates products what can be use for the treatment of disease of heart head blood-vessel, cancer,mental sickness and respiratory disease .

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across br...
Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice. We create value for customers through manufacturing excellence, reliable quality and innovative science. Our people are the experts that our customers enjoy working with.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of product development, custom synthesis, contract research and contract manufacturing. Centaur formulations and API are exported across 5 continents and more than 60 count...
Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of product development, custom synthesis, contract research and contract manufacturing. Centaur formulations and API are exported across 5 continents and more than 60 countries including regulated markets. Formulations Centaur ranks among India's TOP 50 pharmaceutical companies by prescriptions (CMarc) and by stockist audit (ORG-IMS). Centaur's All-India network includes a 1000 strong sales force that covers 250,000 doctors and 250,000 retailers every month. Over 50 million prescriptions of Centaur brands are generated by doctors of all specialities, annually. Prescription audits (ORG-IMS & CMarc) confirm that Sinarest is a clear leader in the Indian Anti-Cold market. One prescription of Sinarest is generated every second by a doctor in India! Centaur has demonstrated its competence in transforming products into strong brands, reinforced by successful extensions, resulting in a formidable presence in key therapy areas. Centaur brands are leaders in six therapeutic segments and rank among the top 3 in six other therapeutic segments. Centaur's manufacturing facilities at GOA conform to WHO-GMP standards, and dosage forms include tablets liquids, injectables (vials and ampoules), eye and ear drops, and ointments. CRAM The current pharma scenario has driven a shift, away from in-house R&D and production to contract research and manufacturing (CRAM). A fully scalable 25,000 square metres formulations facility conforming to USFDA / EU standards has been set up in Pune with a focus on oral solids. API Centaur is India's largest manufacturer and exporter of Psychotropic API and have introduced 24 API for the first time in India. Our API manufacturing facility near Mumbai conforms to USFDA standards and our clientele includes Big Pharma, generic majors and Indian multinationals. Our specialisation ranges from API and intermediates to custom synthesis and process chemistry. An integrated approach ensures that we can scale up capabilities from conceptualisation to commercialisation. CRO A 10,000 square feet, ultra-modern, contract research organisation (CRO) with a 36 bed clinical pharmacology unit (CPU), has been set up at Centaur House, our corporate headquarters. Facilities include Bio-availability (BA), Bio-equivalence (BE), Bio-analysis & Clinical trials. State-of-the-art R&D laboratories dedicated to formulations and API, approved by the Government of India are also located at Centaur House. Future By strategically positioning itself for collaborative relationships, Centaur has tied up with the world's leading players, by offering high performance value options and critical capabilities. We believe that our core competencies in API, formulations, CRAM and CRO will enhance business volumes and help us ascend the pharmaceutical value chain. This would help us realise our vision of emerging as a 'fully integrated global pharmaceutical player'.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharmaceuticals, Nishchem International Pvt. Ltd. (NIPL) stands on the virtue of revolutionizing the ends, as well as the means to safe and secure health. Medicinal drugs have ...
Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharmaceuticals, Nishchem International Pvt. Ltd. (NIPL) stands on the virtue of revolutionizing the ends, as well as the means to safe and secure health. Medicinal drugs have always held an important place in the sphere of healing and treatment, with their applications ranging from diagnosis, treatment and cure right up to prophylaxis.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a strong network of industry professionals who care capable of handling the development of APIs, several Ready-to-fill Pellets and other intermediates, and chemicals. The co...
Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a strong network of industry professionals who care capable of handling the development of APIs, several Ready-to-fill Pellets and other intermediates, and chemicals. The company’s influence has a universal reach coordinating with multi-levels of global healthcare service providers for generic drugs. It holds a valued equity in niche pharma sectors in USA, Europe and Africa. Precise Group’s business encompasses the protection of the interest of their shareholders, is complaint with international regulatory bodies and meets the protocol favored in any region as a pharma suppler spanning developed and new markets. The technologically advanced manufacturing hub near Mumbai conducts manufacturing programs to sustain quality drugs at cost effect prices.

PharmaCompass >>

First
Previous
Next
Last